Shiga toxins 1 and 2 translocate differently across polarized intestinal epithelial cells

Infection and Immunity

Volumn 67, Issue 12, 1999, Pages 6670-6677

  Hurley, Bryan P ^a   Jacewicz, Mary ^a   Thorpe, C M ^a   Lincicome, Lisa L ^a   King, Andrew J ^a   Keusch, Gerald T ^a,b   Acheson, David W K ^a  

^a TUFTS MEDICAL CENTER   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLCHICINE; SHIGA TOXIN;

ACUTE KIDNEY FAILURE; ANIMAL CELL; ARTICLE; DIARRHEA; DISEASE SEVERITY; ENDOCYTOSIS; ENZYME ACTIVITY; ESCHERICHIA COLI; GENE TRANSLOCATION; HEMOLYTIC UREMIC SYNDROME; HUMAN; HUMAN CELL; INTESTINE EPITHELIUM CELL; MONKEY; NONHUMAN; PRIORITY JOURNAL; SEROTYPE; SHIGELLA DYSENTERIAE;

ANIMALS; BACTERIAL TOXINS; BIOLOGICAL TRANSPORT; BREFELDIN A; CELL LINE; CELL POLARITY; CERCOPITHECUS AETHIOPS; COLCHICINE; EPITHELIAL CELLS; HUMANS; INTESTINAL MUCOSA; MONENSIN; SHIGA TOXINS; VERO CELLS;

EID: 0032720195     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Acheson, D. W. K., S. De Breucker, A. Donohue-Rolfe, K. Kozak, A. Yi, and G. T. Keusch. 1994. Enzyme immunoassay for direct detection of Shiga-like toxins in stool samples, abstr. B-62, p. 39. In Abstracts of the 94th General Meeting of the American Society for Microbiology 1994. American Society for Microbiology, Washington, D.C.
2. Acheson, D. W. K., A. Donohue-Rolfe, and G. T. Keusch. 1991. The family of Shiga and Shiga-like toxins, p. 415-433. In J. E. Alouf and J. H. Freer (ed.), Sourcebook of bacterial protein toxins. Academic Press Ltd., London, United Kingdom.
3. Acheson, D. W. K., M. Jacewicz, A. V. Kane, A. Donohue-Rolfe, and G. T. Keusch. 1993. One step high yield affinity purification of shiga-like toxin II variants and quantitation using enzyme linked immunosorbent assays. Microb. Pathog. 14:57-66.
4. Acheson, D. W. K., R. Moore, S. De Breucker, L. Lincicome, M. Jacewicz, E. Skutelsky, and G. T. Keusch. 1996. Translocation of Shiga toxin across polarized intestinal cells in tissue culture. Infect. Immun. 64:3294-3300.
5. Apodaca, G., M. Bomsel, J. Arden, P. P. Breitfield, K. Tang, and K. E. Mostov. 1991. The polymeric immunoglobulin receptor: a model protein to study transcytosis. J. Clin. Investig. 87:1877-1882.
6. Boerlin, P., S. A. McEwen, F. Boerlin-Petzold, J. B. Wilson, V. Johnson, and C. L. Gyles. 1999. Associations between virulence factors of Shiga toxin-producing Escherichia coli and disease in humans. J. Clin. Microbiol. 37:497-503.
7. Deffback, M. E., C. J. Bryan, and C. M. Roy. 1996. Protein movement across cultured guinea pig trachea: specificity and effect of transcytosis inhibitors. Am. J. Physiol. 271:L744-L752.
8. Donohue-Rolfe, A., D. W. K. Acheson, A. V. Kane, and G. T. Keusch. 1989. Purification of Shiga and Shiga-like toxins I and II by receptor analog affinity chromatography with immobilized Pl glycoprotein and the production of cross-reactive monoclonal antibodies. Infect. Immun. 57:3888-3893.
9. Donohue-Rolfe, A., M. A. Kelley, M. Bennish, and G. T. Keusch. 1986. Enzyme-linked immunosorbent assay for Shigella toxin. J. Clin. Microbiol. 24:65-68.
10. Endo, Y., K. Tsurugi, T. Yutsudo, Y. Takeda, T. Ogasawara, and K. Igarashi. 1988. Site of action of vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins. Eur. J. Biochem. 171:45-50.
11. Francis, D. H., R. A. Moxley, and C. Y. Andraos. 1989. Edema disease-like brain lesions in gnotobiotic piglets infected with Escherichia coli serotype O157:H7. Infect. Immun. 57:1339-1342.
12. Garred, O., E. Dubinina, P. K. Holm, S. Olsnes, B. Van Deurs, J. V. Kozlov, and K. Sandvig. 1995. Role of processing and intracellular transport for optimal toxicity of Shiga toxin and toxin mutants. Exp. Cell Res. 218:39-49.
13. Griffin, P. M. 1995. Escherichia coli O157:H7 and other enterohemorrhagic Escherichia coli, p. 739-761. in M. J. Blaser, P. D. Smith, J. L. Ravdin, H. B. Greenberg, and R. L. Guerrant (ed.), Infections of the gastrointestinal tract. Raven Press, Ltd., New York, N.Y.
14. Hecht, G., A. Koutsouris, C. Pothoulakis, J. T. LaMont, and J. L. Madara. 1992. Clostridium difficile toxin B disrupts the barrier function of T84 monolayers. Gastroenterology 102:416-423.
15. Heyman, M., A. Crain-Dinoyelle, S. K. Nath, and J. F. Desjeux. 1990. Quantification of protein transcytosis in the human colon carcinoma cell line CaCo-2. J. Cell. Physiol. 143:391-395.
16. Jacewicz, M. S., D. W. K. Acheson, D. G. Binion, G. A. West, L. L. Lincicome, C. Fiocchi, and G. T. Keusch. 1999. Responses of human intestinal microvascular endothelial cells to Shiga toxins 1 and 2 and pathogenesis of hemorrhagic colitis. Infect. Immun. 67:1439-1444.
17. Jacewicz, M. S., D. W. K. Acheson, M. Mobassaleh, A. Donohue-Rolfe, K. A. Balasubramanian, and G. T. Keusch. 1995. Maturational regulation of globotriaosylceramide, the Shiga-like toxin 1 receptor, in cultured human gut epithelial cells. J. Clin. Investig. 96:1328-1335.
18. Keusch, G. T., and D. W. K. Acheson. 1997. Thrombotic thrombocytopenia purpura with Shiga toxins. Semin. Hematol. 34:106-116.
19. Lencer, W. L., S. Moe, P. A. Rufo, and J. L. Madara. 1995. Transcytosis of cholera toxin subunits across model human intestinal epithelia. Proc. Natl. Acad. Sci. USA 92:10094-10098.
20. Ma, T. Y., D. Hollander, L. T. Tran, D. Nguyen, N. Hoa, and D. Bhalla. 1995. Cytoskeletal regulation of Caco-2 intestinal monolayer paracellular permeability. J. Cell. Physiol. 164:533-545.
21. Madara, J. L. 1998. Regulation of the movement of solutes across tight junctions. Annu. Rev. Physiol. 60:143-159.
22. Melton-Celsa, A. R., and A. D. O'Brien. 1998. Structure, biology, and relative toxicity of Shiga toxin family members for cells and animals, p. 121-128. In J. B. Kaper and A. D. O'Brien (ed.), Escherichia coli O157:H7 and other Shiga toxin-producing E. coli strains. American Society for Microbiology, Washington, D.C.
23. Milford, D. V., M. C. Taylor, P. E. Rose, T. C. F. Roy, and B. Rowe. 1989. Immunologic therapy for hemolytic-uremic syndrome. J. Pediatr. 502-504. (Letter to the editor.)
24. Nataro, J. P., and J. B. Kaper. 1998. Diarrheagenic Escherichia coli. Clin. Microbiol. Rev. 11:142-201.
25. Obrig, T. G. 1998. Interaction of Shiga toxins with endothelial cells, p. 303-311. In J. B. Kaper and A. D. O'Brien (ed.), Escherichia coli O157:H7 and other Shiga toxin-producing E. coli strains. American Society for Microbiology, Washington, D.C.
26. Ostroff, S. M., P. L. Tarr, M. A. Neill, J. H. Lewis, N. Hargrett-Bean, and J. M. Kobayashi. 1989. Toxin genotypes and plasmid profiles as determinants of systemic sequelae In Escherichia coli O157:H7 infections. J. Infect. Dis. 160:994-998.
27. Parkos, C. A., C. Delp, M. A. Arnaout, and J. L. Madara. 1991. Neutrophil migration across a cultured intestinal epithelium. Dependence on a CD11b/ CD18-mediated event and enhanced efficiency in a physiological direction. J. Clin. Investig. 88:1605-1612.
28. Paton, J. C., and A. W. Paton. 1998. Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections. Clin. Microbiol. Rev. 11:450-479.
29. Philpott, D. J., C. A. Ackerley, A. J. Kiliaan, M. A. Karmali, M. H. Perdue, and P. M. Sherman. 1997. Translocation of verotoxin-1 across T84 monolayers: mechanism of bacterial toxin penetration of epithelium. Am. J. Physiol. 273:01349-01358.
30. Pickering, L. K., T. G. Obrig, and F. B. Stapleton. 1994. Hemolytic-uremic syndrome and enterohemorrhagic Escherichia coli. Pediatr. Infect. Dis. J. 13:459-476.
31. Sandvig, K., and B. Van Deurs. 1996. Endocytosis, intracellular transport, and cytotoxic action of Shiga toxin and ricin. Physiol. Rev. 76:949-966.
32. Scotland, S. M., G. A. Willshaw, H. R. Smith, and B. Rowe. 1987. Properties of strains of Escherichia coli belonging to serogroup O157 with special reference to production of vero cytotoxins VT1 and VT2. Epidemiol. Infect. 99:613-624.
33. Tartakoff, A. M. 1983. Perturbation of vesicular traffic with the carboxylic ionophore monensin. Cell 32:1026-1028.
34. Tesh, V. L., J. A. Burris, J. W. Owens, V. M. Gordon, E. A. Wadolkowski, A. D. O'Brien, and J. E. Samuel. 1993. Comparison of the relative toxicities of Shiga-like toxin type 1 and type 2 for mice. Infect. Immun. 61:3392-3402.
35. Thomas, A., H. Chart, T. Cheasty, H. R. Smith, J. A. Frost, and B. Rowe. 1993. Vero cytotoxin-producing Escherichia coli, particularly serogroup O157, associated with human infections in the United Kingdom: 1989-1991. Epidemiol. Infect. 110:591-600.
36. Tome, C. D. 1995. Transport of beta-lactoglobulin and alpha-lactalbumin in enterocyte-like Caco-2 cells. Reprod. Nutr. Dev. 35:179-188.
37. Wadolkowski, E. A., L. M. Sung, J. A. Burris, J. E. Samuel, and A. D. O'Brien. 1990. Acute renal tubular necrosis and death of mice orally infected with Escherichia coli strains that produce Shiga-like toxin type 2. Infect. Immun. 58:3959-3965.
38. Wan, J., M. E. Taub, D. Shah, and W. C. Shen. 1992. Brefeldin A enhances receptor-mediated transcytosis of transferrin in filter-grown Madin-Darby canine kidney cells. J. Biol. Chem. 267:13446-13450.